NeoGenomics
90 hedge funds and large institutions have $139M invested in NeoGenomics in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 16 closing their positions.
704% more call options, than puts
Call options by funds: $201K | Put options by funds: $25K
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
2% more funds holding
Funds holding: 88 → 90 (+2)
8% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 26
20% less capital invested
Capital invested by funds: $175M → $139M (-$35.8M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
Top Sellers
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$3.51M |
| 2 |
WSA
Wall Street Associates
Lajolla,
California
|
-$3.26M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$2.99M |
| 4 |
GP
Grow Partners
San Diego,
California
|
-$1.75M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.48M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GA
101
Geneva Advisors
Chicago,
Illinois
| – | -$52K | -10,000 | Closed |
|
102
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$10 | -2,010 | Closed |
|
103
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$8K | -1,605 | Closed |
|
104
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | -300 | Closed |
|
105
Barclays
London,
United Kingdom
| – | -$1K | -136 | Closed |
|
106
Citigroup
New York
| – | +$308 | +67 | New |
|
NEO Hedge Fund Activity: Q4 2014 in Review
90 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2014, worth a combined $139M — down 20% from $175M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new NEO positions and 16 closed out — a net gain of 3 holders — while 28 added to existing stakes and 26 trimmed.
The largest buyer was Artisan Partners, adding an estimated $6.42M. The largest seller was Northpointe Capital, cutting an estimated $3.51M.
- 90 institutional investors held NeoGenomics (NEO) as of Q4 2014, up from 88 in Q3 2014.
- Funds reported $139M of NeoGenomics stock for Q4 2014, down 20% quarter-over-quarter.
- 19 funds opened new NeoGenomics positions in Q4 2014 and 16 closed out, a net change of +3 holders.
- The largest NeoGenomics buyer in Q4 2014 was Artisan Partners, an estimated $6.42M added.
- The largest NeoGenomics seller in Q4 2014 was Northpointe Capital, an estimated $3.51M sold.
Based on aggregated 13F filings for Q4 2014.